Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve repair or replacement (TMVR), transcatheter and surgical valve repairs, and surgical replacement valves. Newer devices are now being used for transcatheter tricuspid valve repair replacement (TTVR). 

Neovasc Tiara, Reducer Transcatheter Devices Featured at CSI Frankfurt 2019 Conference
News | Heart Valve Technology | July 09, 2019
July 9, 2019 — Neovasc Inc. announced that its Tiara transcatheter mitral valve replacement (TMVR) device and its...
AI Algorithm Assists in Detection of Aortic Stenosis
News | Stethoscopes | July 08, 2019
July 8, 2019 — Berkeley, Calif.-based digital health company Eko unveiled an investigational aortic stenosis (AS)...
FEops HEARTguide Wins CSI Highlight of the Year Award
News | Structural Heart | July 05, 2019
July 5, 2019 — FEops announced that FEops HEARTguide was the winning entry at CSI Frankfurt 2019 voted on by physician...
Study Shows Inducing a Heart Attack Helps Valve Patients. This image shows a left-ventricular outflow tract (LVOT) obstructed by an Edwards Sapien TAVR valve used for a valve-in-valve procedure. The arrow points to the small, crescent shaped dark area of the neo-LVOT, which did not allow enough blood to flow from the left ventricle into the aorta and the rest of the body. To prevent this issue, the procedure used by Henry Ford ablates some of the tissue in the septum to allow for a larger LVOT area.

This image shows a left-ventricular outflow tract (LVOT) obstructed by an Edwards Sapien TAVR valve used for a valve-in-valve procedure. The arrow points to the small, crescent shaped dark area of the neo-LVOT, which did not allow enough blood to flow from the left ventricle into the aorta and the rest of the body. To prevent this issue, the procedure used by Henry Ford ablates (kills) some of the tissue in the cardiac septum to allow these valves to fit better and allow for an enlarged neo-LVOT for patients who otherwise could not receive this therapy. 

News | Heart Valve Technology | July 03, 2019
July 3, 2019 — A study of a procedure developed at Henry Ford Health System shows inducing a heart attack in patients...
Videos | Heart Failure | June 28, 2019
Federico Asch, M.D., FASE, director of cardiac imaging research and director of the cardiovascular imaging lab, MedStar...
CMS Finalizes Updates to Coverage Policy for Transcatheter Aortic Valve Replacement
Feature | Heart Valve Technology | June 24, 2019
June 24, 2019 — The Centers for Medicare and Medicaid Services (CMS) recently finalized its decision to update the...
New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
June 20, 2019 – VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between...
Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite
Technology | Advanced Visualization | June 13, 2019
June 13, 2019 — Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food and...
Abbott Tricuspid Valve Repair System Reduces Tricuspid Regurgitation at 30 Days
News | Heart Valve Technology | June 11, 2019
June 11, 2019 — Abbott recently announced positive late-breaking data from its TRILUMINATE study of the company's...
DSM and SAT Partnering to Develop Next-Generation, Cost-Effective Heart Valve
News | Heart Valve Technology | June 04, 2019
June 4, 2019 — Royal DSM recently announced a collaboration with Strait Access Technologies (SAT), to develop the world...

The MitraClip is one example of a transcatheter mitral valve repair or replacement (TMVR) device used in the structural heart repair program at Henry Ford Hospital.

Podcast | Heart Valve Technology | May 31, 2019
Marvin Eng, M.D., structural fellowship director at Henry Ford Health System, and William O'Neill, M.D., director of...

William O'Neill, M.D., and Adam Greenbaum, M.D., perform a transcatheter aortic valve replacement (TAVR) procedure in the cath lab at Henry Ford Hospital in Detroit.

Podcast | Structural Heart | May 31, 2019
A discussion with William O’Neill, M.D., director of the Henry Ford structural heart program, Ruth Fisher, MBA, vice...
Using the terms plumber, electrician, carpenter are easy for most patients to understand when explaining the rolls of specialists in complex cardiology procedures. In this image, interventional cardiologist "plumbers" and a cardiac surgeon "carpenter" work as part of the a structural heart team at Henry Ford Hospital while guiding the device using live echo images from the "video guy."

Using the terms plumber, electrician and carpenter are easy ways for most patients to understand when explaining the roles of specialists in complex cardiology procedures. In this image, interventional cardiologist "plumbers" and a cardiac surgeon "carpenter" work as part of the a structural heart team at Henry Ford Hospital while guiding the device using live echo images from the "video guy." 

Blog | May 28, 2019
Physicians use many strategies to better interface with patients and their families to try and explain in non-physician...
Illustration showing the catheter steps for the LAMPOON procedure designed to prevent left ventricular outflow tract (LVOT) obstruction . From Dr. Jaffar M. Khan and the Laboratory of Cardiovascular Intervention, led by Dr. Robert J. Lederman.

Figure 1: Illustration showing the catheter steps for the LAMPOON procedure. From Dr. Jaffar M. Khan and the Laboratory of Cardiovascular Intervention, led by Dr. Robert J. Lederman.

Feature | Heart Valve Technology | May 22, 2019
Researchers at the National, Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH...
Edwards Announces Research Milestones for Pascal Transcatheter Mitral Valve Program
News | Heart Valve Technology | May 22, 2019
May 22, 2019 — Edwards Lifesciences Corp. announced strategic clinical and regulatory milestones for its Edwards Pascal...